GlucoModicum's non-invasive CGM nears first filing Finland's GlucoModicum thinks it is in the lead in the race to bring a non-invasive continuous glucose monitor (CGM) to market.

Finnish #medtech company #GlucoModicum has taken a step closer to bringing its non-invasive #continuousglucosemonitor (CGM) device to market after completing a clinical trial involving hundreds of subjects.